Physician profile
Alexander Vance
NPI 1730683335
$488.84
in general payments reported to CMS, 2019-2025
14 companies · $47.50 in 2025
The $47.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.32 · 2022: $274 · 2023: $48.57 · 2024: $46.91 · 2025: $47.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $101.72 | 2021-2022 | |
| Abbott Laboratories | $69.20 | 2022-2023 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $47.50 | 2025 | Inspire |
| Biogen, INC. | $39.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.53 | 2022-2024 | Vaxelis, Gardasil 9, Gardasil |
| Biohaven Pharmaceutical Holding Company LTD. | $33.84 | 2022 | |
| Glaxosmithkline, LLC. | $28.78 | 2022-2024 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $28.43 | 2021 | |
| Sanofi Pasteur INC. | $26.29 | 2023 | |
| Exact Sciences Corporation | $18.53 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $16.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.54 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.